Assessment of benefits of a universal screen for maternal alcohol use during pregnancy
- 1 October 2010
- journal article
- research article
- Published by Wiley in Birth Defects Research Part A: Clinical and Molecular Teratology
- Vol. 88 (10) , 838-846
Abstract
INTRODUCTION: The objective of this report is to estimate the benefits of universal meconium screening for maternal drinking during pregnancy. Fetal alcohol spectrum disorder (FASD), including its most severe manifestation fetal alcohol syndrome (FAS), is preventable and remains a public health tragedy. The incidences of FAS and FASD have been conservatively estimated to be 0.97 and 10 per 1000 births, respectively. Meconium testing has been demonstrated to be a promising at‐birth method for detection of drinking during pregnancy. METHODS: The current costs of FAS and FASD, alcohol treatment programs, and meconium screening were estimated by literature review. Monetary values were converted roughly to equal dollars in 2006. RESULTS: Costs of adding meconium analysis to the current newborn screening program and of treatment for the identified mothers were estimated and compared to potential averted costs that may result from identification and intervention for mothers and affected infants. Three potential maternal treatment strategies are analyzed. Depending on the treatment type, the savings may range from $6 to $97 for every $1 spent on screening and treatment. DISCUSSION: It needs to be emphasized, however, that such screening is premature and that to be effective this screening can be implemented only if there is a societal willingness to institute prevention and intervention programs to improve both women's and children's health. Future research should be directed at improving detection and developing in‐depth prevention and remedial intervention programs. A thorough consideration of the ethical issues involved in such a screening program is also needed. Birth Defects Research (Part A), 2010.Keywords
This publication has 38 references indexed in Scilit:
- Screening, Diagnosing and Prevention of Fetal Alcohol Syndrome: Is This Syndrome TreatableDevelopmental Neuroscience, 2010
- Universal or Targeted Screening for Fetal Alcohol Exposure: A Cost-Effectiveness AnalysisTherapeutic Drug Monitoring, 2009
- Impaired Eyeblink Conditioning in Children With Fetal Alcohol SyndromeAlcohol, Clinical and Experimental Research, 2007
- Moderate Prenatal Alcohol Exposure and Cognitive Status of Children at Age 10Alcohol, Clinical and Experimental Research, 2006
- Fatty Acid Ethyl Esters: Quantitative Biomarkers for Maternal Alcohol ConsumptionThe Journal of Pediatrics, 2005
- Validation of a new biomarker of fetal exposure to alcoholThe Journal of Pediatrics, 2003
- Relation of Maternal Age and Pattern of Pregnancy Drinking to Functionally Significant Cognitive Deficit in InfancyAlcohol, Clinical and Experimental Research, 1998
- Effects of Fetal Alcohol Exposure on Infant Reaction TimeAlcohol, Clinical and Experimental Research, 1994
- Maternal Drinking During Pregnancy: Attention and Short‐Term Memory in 14‐Year‐Old Offspring—A Longitudinal Prospective StudyAlcohol, Clinical and Experimental Research, 1994
- Fetal alcohol syndrome in familiesNeurotoxicology and Teratology, 1988